Financhill
Back

Madrigal Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
47

MDGL
Madrigal Pharmaceuticals

Last Price:
242.38
Seasonality Move:
23.49%
Sell
37

SRPT
Sarepta Therapeutics

Last Price:
127.11
Seasonality Move:
0.19%
Sell
47
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $233.33. The Score for MDGL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $125.01. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $233.33
    The current trend is relatively stagnant and MDGL is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $125.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.37 Sell
Relative Strength Index (14 RSI): 39.26 Sell
Chaikin Money Flow: -56242 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (236.75 - 253.29) Sell
Bollinger Bands (100): (225.94 - 277.64) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.92 Sell
Relative Strength Index (14 RSI): 32.69 Sell
Chaikin Money Flow: -233066 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (127.43 - 139.51) Sell
Bollinger Bands (100): (124.47 - 147.63) Sell

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 235.51 Sell
20-day SMA: 243.56 Sell
50-day SMA: 258.23 Sell
200-day SMA: 242.61 Sell
8-day EMA: 236.38 Sell
20-day EMA: 242.2 Sell
50-day EMA: 250.62 Sell
200-day EMA: 239.83 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.01 Sell
20-day SMA: 132.96 Sell
50-day SMA: 138.54 Sell
200-day SMA: 126.19 Sell
8-day EMA: 126.73 Sell
20-day EMA: 130.78 Sell
50-day EMA: 134.9 Sell
200-day EMA: 128.87 Sell

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.42 per share, an increase next quarter of $3.05 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):